India vs New Zealand: Proportion of isolates with decreased susceptibility or resistance
India
0
in 2020
New Zealand
0.1
in 2020
India rank
13th
New Zealand rank
11th
Proportion of isolates with decreased susceptibility or resistance over time
- India
- New Zealand
How they compare
New Zealand currently reports 0.1 against 0 in India, a difference of 0.1.
The two have swapped places 3 times across 10 shared years of data; in 2009 it was India ahead.
India ranks 13th and New Zealand ranks 11th of 52 countries.
Across the 3 decades both report, India averaged higher in 2 and New Zealand in 1.
Head to head by decade
| Decade | India | New Zealand | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 10.81 | 0 | 10.81 | India |
| 2010s | 3.72 | 0.3595 | 3.36 | India |
| 2020s | 0 | 0.1 | 0.1 | New Zealand |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher proportion of isolates with decreased susceptibility or resistance, India or New Zealand?
- New Zealand, at 0.1 against 0 in India as of 2020.
- What is the difference in proportion of isolates with decreased susceptibility or resistance between India and New Zealand?
- 0.1, with New Zealand ahead.
- How many years of comparable data are there for India and New Zealand?
- 10 years are reported by both, from 2009 to 2020.
- How do India and New Zealand rank globally for proportion of isolates with decreased susceptibility or resistance?
- India ranks 13th and New Zealand ranks 11th of 52 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Proportion of isolates with decreased susceptibility or resistance (DS/R) to ceftriaxone reported to WHO-GASP. Statizoid refreshes it automatically from the source and publishes the full history for both places.